2021 annual financial data
Fulcrum Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -409.53%.
Operating income was -81,054,000 USD and net income was -78,332,000 USD.
Operating cash flow was -78,478,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,163,000 USD
- Operating income
- -81,054,000 USD
- Net income
- -78,332,000 USD
- Operating cash flow
- -78,478,000 USD